150 related articles for article (PubMed ID: 33054597)
41. Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation.
Wang JY; Jiang MW; Li MY; Zhang ZH; Xing Y; Ri M; Jin CH; Xu GH; Piao LX; Jin HL; Ma J; Jin Y; Zuo HX; Jin X
J Nutr Biochem; 2022 Feb; 100():108899. PubMed ID: 34748924
[TBL] [Abstract][Full Text] [Related]
42. B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma.
Li L; Zhang J; Chen J; Xu-Monette ZY; Miao Y; Xiao M; Young KH; Wang S; Medeiros LJ; Wang M; Ford RJ; Pham LV
Blood; 2018 Oct; 132(17):1805-1817. PubMed ID: 30209121
[TBL] [Abstract][Full Text] [Related]
43. Silencing of Eag1 Gene Inhibits Osteosarcoma Proliferation and Migration by Targeting STAT3-VEGF Pathway.
Wu X; Chen Z; Zeng W; Zhong Y; Liu Q; Wu J
Biomed Res Int; 2015; 2015():617316. PubMed ID: 26783521
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-519d-3p antagonizes osteosarcoma resistance against cisplatin by targeting PD-L1.
Wang J; Zhang Z; Qiu C; Wang J
Mol Carcinog; 2022 Mar; 61(3):322-333. PubMed ID: 34780678
[TBL] [Abstract][Full Text] [Related]
45. TRIM59 promotes osteosarcoma progression via activation of STAT3.
Xu G; Ma Z; Yang F; Bai Y; Li J; Luo W; Zhong J
Hum Cell; 2022 Jan; 35(1):250-259. PubMed ID: 34625908
[TBL] [Abstract][Full Text] [Related]
46. S100A14: A novel negative regulator of cancer stemness and immune evasion by inhibiting STAT3-mediated programmed death-ligand 1 expression in colorectal cancer.
Min HY; Cho J; Sim JY; Boo HJ; Lee JS; Lee SB; Lee YJ; Kim SJ; Kim KP; Park IJ; Hong SM; Zhang XL; Zhang ZG; Park RW; Lee HY
Clin Transl Med; 2022 Jul; 12(7):e986. PubMed ID: 35858011
[TBL] [Abstract][Full Text] [Related]
47. Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells.
Feng J; Yang H; Zhang Y; Wei H; Zhu Z; Zhu B; Yang M; Cao W; Wang L; Wu Z
Oncogene; 2017 Oct; 36(42):5829-5839. PubMed ID: 28604752
[TBL] [Abstract][Full Text] [Related]
48. Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells.
Yuan LW; Jiang XM; Xu YL; Huang MY; Chen YC; Yu WB; Su MX; Ye ZH; Chen X; Wang Y; Lu JJ
Phytomedicine; 2021 Jan; 80():153394. PubMed ID: 33130472
[TBL] [Abstract][Full Text] [Related]
49. The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer.
Zhang N; Zeng Y; Du W; Zhu J; Shen D; Liu Z; Huang JA
Int J Oncol; 2016 Oct; 49(4):1360-8. PubMed ID: 27499357
[TBL] [Abstract][Full Text] [Related]
50. NME4 modulates PD-L1 expression via the STAT3 signaling pathway in squamous cell carcinoma.
Zheng S; Liu Q; Liu T; Yang L; Zhang Q; Shen T; Zhang X; Han X; Lu X
Biochem Biophys Res Commun; 2020 May; 526(1):29-34. PubMed ID: 32192776
[TBL] [Abstract][Full Text] [Related]
51. Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma.
Wang YC; Zheng LH; Ma BA; Zhou Y; Zhang MH; Zhang DZ; Fan QY
Acta Histochem; 2011 Jul; 113(4):402-8. PubMed ID: 20546860
[TBL] [Abstract][Full Text] [Related]
52. The mechanism underlying arsenic-induced PD-L1 upregulation in transformed BEAS-2B cells.
Wang H; Li J; Xu W; Li C; Wu K; Chen G; Cui J
Toxicol Appl Pharmacol; 2022 Jan; 435():115845. PubMed ID: 34953898
[TBL] [Abstract][Full Text] [Related]
53. Tumor-associated macrophages induce PD-L1 expression in gastric cancer cells through IL-6 and TNF-ɑ signaling.
Ju X; Zhang H; Zhou Z; Chen M; Wang Q
Exp Cell Res; 2020 Nov; 396(2):112315. PubMed ID: 33031808
[TBL] [Abstract][Full Text] [Related]
54. Characterization of STAT3 activation and expression in canine and human osteosarcoma.
Fossey SL; Liao AT; McCleese JK; Bear MD; Lin J; Li PK; Kisseberth WC; London CA
BMC Cancer; 2009 Mar; 9():81. PubMed ID: 19284568
[TBL] [Abstract][Full Text] [Related]
55. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas.
Yoon CJ; Chang MS; Kim DH; Kim W; Koo BK; Yun SC; Kim SH; Kim YS; Woo JH
Gastric Cancer; 2020 Sep; 23(5):780-795. PubMed ID: 32206940
[TBL] [Abstract][Full Text] [Related]
56. Regulation of PD-L1: a novel role of pro-survival signalling in cancer.
Chen J; Jiang CC; Jin L; Zhang XD
Ann Oncol; 2016 Mar; 27(3):409-16. PubMed ID: 26681673
[TBL] [Abstract][Full Text] [Related]
57. Expression of miR-29 and STAT3 in osteosarcoma and its effect on proliferation regulation of osteosarcoma cells.
Li MH; Wu ZY; Wang Y; Chen FZ; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7275-7282. PubMed ID: 31539114
[TBL] [Abstract][Full Text] [Related]
58. Serine/Threonine Kinase 35, a Target Gene of STAT3, Regulates the Proliferation and Apoptosis of Osteosarcoma Cells.
Wu Z; Liu J; Hu S; Zhu Y; Li S
Cell Physiol Biochem; 2018; 45(2):808-818. PubMed ID: 29414823
[TBL] [Abstract][Full Text] [Related]
59. High linear energy transfer carbon-ion irradiation upregulates PD-L1 expression more significantly than X-rays in human osteosarcoma U2OS cells.
Permata TBM; Sato H; Gu W; Kakoti S; Uchihara Y; Yoshimatsu Y; Sato I; Kato R; Yamauchi M; Suzuki K; Oike T; Tsushima Y; Gondhowiardjo S; Ohno T; Yasuhara T; Shibata A
J Radiat Res; 2021 Sep; 62(5):773-781. PubMed ID: 34196706
[TBL] [Abstract][Full Text] [Related]
60. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
Homma S; Hayashi K; Yoshida K; Sagawa Y; Kamata Y; Ito M
Int Immunopharmacol; 2018 Jan; 54():39-45. PubMed ID: 29100036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]